Abstract
This current work has been conducted mainly to increase solubility and drug release properties for high hydrophobic Dentatin (DEN) by incorporation it into Hydroxypropyl-β-Cyclodextrin (HPβCD) cavity. To confirm that inclusion be succeeded, the produced complex were installed onto different machines. The latter includes: Fourier transform infrared spectroscopy (FT-IR), X-ray diffractometry (XRD), differential scanning calorimetry (DSC), and field emission-scanning electron microscopy (FE-SEM). The hydrodynamic diameter and zeta potential of DEN-HPβCD complex were 2.025 ± 0.39 nm and −33.6 mV, respectively. Ultra-violet spectroscopy was employed to further confirmation of complexation process as well as to determine drug release profile. The result showed an initial burst release (19.9% within first two minutes) and then a continuous release for an extended period of 41 h (100%). The solubility of DEN was enhanced by >300 fold following complexation when a compared to DEN alone. Moreover, MTT finding showed that this complexation did not reduce cytotoxicity of DEN after applying on prostate cancer (LNCaP), human adenocarcinoma breast cancer (MDA-MB-231) and human gastric adenocarcinoma cell line (HDT). However, further investigations are required to validate efficacy of our produced inclusion using molecular analysis and in vivo studies.
Similar content being viewed by others
References
Merisko-Liversidge, E.M., Liversidge, G.G.: Drug nanoparticles: formulating poorly water-soluble compounds. Toxicol. Pathol. 36(1), 43–48 (2008)
Shaikh, J., Ankola, D., Beniwal, V., Singh, D., Kumar, M.R.: Nanoparticle encapsulation improves oral bioavailability of curcumin by at least 9-fold when compared to curcumin administered with piperine as absorption enhancer. Eur. J. Pharm. Sci. 37(3), 223–230 (2009)
Szejtli, J.: Introduction and general overview of cyclodextrin chemistry. Chem. Rev. 98(5), 1743–1754 (1998)
Loftsson, T., Brewster, M.E.: Pharmaceutical applications of cyclodextrins: basic science and product development. Journal of pharmacy and pharmacology. 62(11), 1607–1621 (2010)
Al-Rawashdeh, N.A., Al-Sadeh, K.S., Al-Bitar, M.-B.: Physicochemical study on microencapsulation of hydroxypropyl-β-cyclodextrin in dermal preparations. Drug Dev Ind Pharm. 36(6), 688–697 (2010)
Harada, A., Hashidzume, A., Takashima, Y.: Cyclodextrin-based supramolecular polymers. In: Supramolecular polymers polymeric betains oligomers. pp. 1–43. Springer, Berlin (2006)
Anirudhan, T.S., Nima, J., Divya, P.L.: Synthesis, characterization and in vitro cytotoxicity analysis of a novel cellulose based drug carrier for the controlled delivery of 5-fluorouracil, an anticancer drug. Appl. Surf. Sci. 355, 64–73 (2015)
Domańska, U., Pelczarska, A., Pobudkowska, A.: Effect of 2-hydroxypropyl-β-cyclodextrin on solubility of sparingly soluble drug derivatives of anthranilic acid. International journal of molecular sciences. 12(4), 2383–2394 (2011)
Danciu, C., Soica, C., Oltean, M., Avram, S., Borcan, F., Csanyi, E., Ambrus, R., Zupko, I., Muntean, D., Dehelean, C.A.: Genistein in 1: 1 inclusion complexes with ramified cyclodextrins: Theoretical, physicochemical and biological evaluation. Int. J. Mol. Sci. 15(2), 1962–1982 (2014)
Singh, R., Bharti, N., Madan, J., Hiremath, S.: Characterization of cyclodextrin inclusion complexes—a review. J. Pharm. Sci. Technol. 2(3), 171–183 (2010).
Aiassa, V., Zoppi, A., Albesa, I., Longhi, M.R.: Inclusion complexes of chloramphenicol with β-cyclodextrin and aminoacids as a way to increase drug solubility and modulate ROS production. Carbohydr. Polym. 121, 320–327 (2015)
Mennini, N., Bragagni, M., Maestrelli, F., Mura, P.: Physico-chemical characterization in solution and in the solid state of clonazepam complexes with native and chemically-modified cyclodextrins. J. Pharm. Biomed. Anal. 89, 142–149 (2014)
Mazzaferro, S., Bouchemal, K., Gallard, J.-F., Iorga, B.I., Cheron, M., Gueutin, C., Steinmesse, C., Ponchel, G.: Bivalent sequential binding of docetaxel to methyl-β-cyclodextrin. Int. J. Pharm. 416(1), 171–180 (2011)
Davis, M.E.: Design and development of IT-101, a cyclodextrin-containing polymer conjugate of camptothecin. Adv. Drug Deliv. Rev. 61(13), 1189–1192 (2009)
Szente, L., Szejtli, J.: Highly soluble cyclodextrin derivatives: chemistry, properties, and trends in development. Adv. Drug Deliv. Rev. 36(1), 17–28 (1999)
Pose-Vilarnovo, B., Perdomo-Lopez, I., Echezarreta-Lopez, M., Schroth-Pardo, P., Estrada, E., Torres-Labandeira, J.J.: Improvement of water solubility of sulfamethizole through its complexation with β-and hydroxypropyl-β-cyclodextrin: characterization of the interaction in solution and in solid state. Eur. J. Pharm. Sci. 13(3), 325–331 (2001)
Yu, Z., Cui, M., Yan, C., Song, F., Liu, Z., Liu, S.: Investigation of heptakis (2, 6-di-O-methyl)-β-cyclodextrin inclusion complexes with flavonoid glycosides by electrospray ionization mass spectrometry. Rapid Commun Mass Spectrom. 21(5), 683–690 (2007)
Blumenthal, R.D., Lew, W., Reising, A., Soyne, D., Osorio, L., Ying, Z., Goldenberg, D.M.: Anti-oxidant vitamins reduce normal tissue toxicity induced by radio-immunotherapy. Int. J. Cancer. 86(2), 276–280 (2000)
Arbab, I.A., Abdul, A.B., Abdelwahab, S.I.: Clausena excavata Burm. f.(Rutaceae): A review of its traditional uses, pharmacological and phytochemical properties. (2015).
Sharif, N.M., Mustahil, N., Noor, N.M., Sukari, M., Rahmani, M., Taufiq-Yap, Y., Ee, G.: Cytotoxic constituents of Clausena excavata. Afr. J. Biotechnol. 10(72), 16337–16341 (2013)
Arbab, I.A., Looi, C.Y., Abdul, A.B., Cheah, F.K., Wong, W.F., Sukari, M.A., Abdullah, R., Mohan, S., Syam, S., Arya, A.: Dentatin induces apoptosis in prostate cancer cells via Bcl-2, Bcl-xL, Survivin downregulation, caspase-9,-3/7 activation, and NF-κB inhibition. Evidence-Based Complementary and Alternative Medicine 2012 (2012).
Kumar, M.: Nano and microparticles as controlled drug delivery devices. J. Pharm. Pharm. Sci. 3(2), 234–258 (2000).
Higuchi, T., Connors, A.: Phase-solubility techniques (1965).
Songsiang, U., Thongthoom, T., Zeekpudsa, P., Kukongviriyapan, V., Boonyarat, C., Wangboonskul, J., Yenjai, C.: Antioxidant activity and cytotoxicity against cholangiocarcinoma of carbazoles and coumarins from Clausena harmandiana. Science-Asia: 38, 75–81 (2012)
Nakamura, T., Kodama, N., Arai, Y., Kumamoto, T., Higuchi, Y., Chaichantipyuth, C., Ishikawa, T., Ueno, K., Yano, S.: Inhibitory effect of oxycoumarins isolated from the Thai medicinal plant Clausena guillauminii on the inflammation mediators, iNOS, TNF-α, and COX-2 expression in mouse macrophage RAW 264.7. J. Nat. Med. 63(1), 21–27 (2009)
Wang, L., Yan, J., Li, Y., Xu, K., Li, S., Tang, P., Li, H.: The influence of hydroxypropyl-β-cyclodextrin on the solubility, dissolution, cytotoxicity, and binding of riluzole with human serum albumin. J. Pharm. Biomed. Anal. 117, 453–463 (2016)
Zhang, L., Zhu, W., Lin, Q., Han, J., Jiang, L., Zhang, Y.: hydroxypropyl-β-cyclodextrin functionalized calcium carbonate microparticles as a potential carrier for enhancing oral delivery of water-insoluble drugs. Int. J. Nanomed. 10, 3291 (2015)
Swaminathan, S., Pastero, L., Serpe, L., Trotta, F., Vavia, P., Aquilano, D., Trotta, M., Zara, G., Cavalli, R.: Cyclodextrin-based nanosponges encapsulating camptothecin: physicochemical characterization, stability and cytotoxicity. Eur. J. Pharm. Biopharm. 74(2), 193–201 (2010)
Sancho, M.I., Russo, M.G., Moreno, M.S., Gasull, E., Blanco, S.E., Narda, G.E.: Physicochemical Characterization of 2-Hydroxybenzophenone with β-cyclodextrin in Solution and Solid State. J. Phys. Chem. B 119(18), 5918–5925 (2015)
Liu, M., Cao, W., Sun, Y., He, Z.: Preparation, characterization and in vivo evaluation of formulation of repaglinide with hydroxypropyl-β-cyclodextrin. Int. J. Pharm. 477(1), 159–166 (2014)
Williams, R.O. III, Mahaguna, V., Sriwongjanya, M.: Characterization of an inclusion complex of cholesterol and hydroxypropyl-β-cyclodextrin. Eur. J. Pharm. Biopharm. 46(3), 355–360 (1998)
Pires, M.A.S., Souza dos Santos, R.A., Sinisterra, R.D.: Pharmaceutical composition of hydrochlorothiazide: β-cyclo-dextrin: Preparation by three different methods, physico-chemical characterization and in vivo diuretic activity evaluation. Molecules 16(6), 4482–4499 (2011)
Klein, S., Wempe, M.F., Zoeller, T., Buchanan, N.L., Lambert, J.L., Ramsey, M.G., Edgar, K.J., Buchanan, C.M.: Improving glyburide solubility and dissolution by complexation with hydroxybutenyl-β-cyclodextrin. J. Pharm. Pharm. 61(1), 23–30 (2009)
Zoeller, T., Dressman, J.B., Klein, S.: Application of a ternary HP-β-CD-complex approach to improve the dissolution performance of a poorly soluble weak acid under biorelevant conditions. Int. J. Pharm. 430(1), 176–183 (2012)
Nasongkla, N., Wiedmann, A.F., Bruening, A., Beman, M., Ray, D., Bornmann, W.G., Boothman, D.A., Gao, J.: Enhancement of solubility and bioavailability of β-lapachone using cyclodextrin inclusion complexes. Pharm. Res. 20(10), 1626–1633 (2003)
Eid, E.E., Abdul, A.B., Suliman, F.E.O., Sukari, M.A., Rasedee, A., Fatah, S.S.: Characterization of the inclusion complex of zerumbone with hydroxypropyl-β-cyclodextrin. Carbohydr. Polym. 83, 1707–1714 (2011)
Vrečer, F., Vrbinc, M., Meden, A.: Characterization of piroxicam crystal modifications. Int. J. Pharm. 256(1), 3–15 (2003)
Su, Y., Rao, S., Cai, Y., Yang, Y.: Preparation and characterization of the inclusion complex of hypocrellin A with hydroxypropyl-β-cyclodextrin. Eur. Food Res. Technol. 231(5), 781–788 (2010)
Huang, Z., Tian, S., Ge, X., Zhang, J., Li, S., Li, M., Cheng, J., Zheng, H.: Complexation of chlorpropham with hydroxypropyl-β-cyclodextrin and its application in potato sprout inhibition. Carbohydr Polym. 107, 241–246 (2014)
Nan, H., Ma, H., Zhang, R., Zhan, R.: Physiochemical properties of the complex of myricetin and hydroxypropyl-β-cyclodextrin. Trop. J. Pharm. Res. 13(11), 1791–1796 (2014)
Liu, B., Zhu, X., Zeng, J., Zhao, J.: Preparation and physicochemical characterization of the supramolecular inclusion complex of naringin dihydrochalcone and hydroxypropyl-β-cyclodextrin. Food Res. Int. 54(1), 691–696 (2013)
Liu, J., Qiu, L., Gao, J., Jin, Y.: Preparation, characterization and in vivo evaluation of formulation of baicalein with hydroxypropyl-β-cyclodextrin. Int. J. Pharm. 312(1), 137–143 (2006)
Albanese, A., Tang, P.S., Chan, W.C.: The effect of nanoparticle size, shape, and surface chemistry on biological systems. Annu. Rev. Biomed. Eng. 14, 1–16 (2012)
Chen, L., Mccrate, J.M., Lee, J.C., Li, H.: The role of surface charge on the uptake and biocompatibility of hydroxyapatite nanoparticles with osteoblast cells. Nanotechnology. 22(10), 105708 (2011)
Al-Rawashdeh, N.A., Al-Sadeh, K.S., Al-Bitar, M.B.: Inclusion complexes of sunscreen agents with β-cyclodextrin: spectroscopic and molecular modeling studies. J. Spectrosc (2013).
Moriwaki, C., Costa, G., Ferracini, C., de Moraes, F., Zanin, G., Pineda, E., Matioli, G.: Enhancement of solubility of albendazole by complexation with β-cyclodextrin. Braz. J. Chem. Eng. 25(2), 255–267 (2008)
Xia, S.-J., Ni, Z.-M., Xu, Q., Hu, B.-X., Hu, J.: Layered double hydroxides as supports for intercalation and sustained release of antihypertensive drugs. J. Solid State Chem. 181(10), 2610–2619 (2008)
Ye, Y.-J., Wang, Y., Lou, K.-Y., Chen, Y.-Z., Chen, R., Gao, F.: The preparation, characterization, and pharmacokinetic studies of chitosan nanoparticles loaded with paclitaxel/dimethyl-β-cyclodextrin inclusion complexes. Int. J. Nanomed. 10, 4309 (2015)
Yousaf, A.M., Kim, D.W., Oh, Y.-K., Yong, C.S., Kim, J.O., Choi, H.-G.: Enhanced oral bioavailability of fenofibrate using polymeric nanoparticulated systems: physicochemical characterization and in vivo investigation. Int. J. Nanomed. 10, 1819 (2015)
Ismail, A., Ahmad, B., Mohd, A., Rasedee, A., Suvitha, S., Behnam, K., Mohamed, Y., Manal-Mohamed, E., Siddig, I., Hapipah, M.: Dentatin isolated from Clausena excavata induces apoptosis in MCF-7cells through the intrinsic pathway with involvement of NF-kB signaling and G0/G1 cell cycle arrest: a bioassay-guided approach. J. Ethnopharmacol. 145, 343–354 (2013)
Ucisik, M.H., Küpcü, S., Schuster, B., Sleytr, U.B.: Characterization of CurcuEmulsomes: nanoformulation for enhanced solubility and delivery of curcumin. J. Nanobiotechnol. 11(1), 1 (2013)
Acknowledgements
This research was supported by science fund research grant (02-01-04-sf1210), Ministry of science, Technology and innovation, Malaysia. The author (Al-Abboodi Sh Ashwaq) is grateful to University of AL-Qadisiyah, Ministry of Higher Education and Scientific Research, Iraq.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Ashwaq, AA.S., Rasedee, A., Abdul, A.B. et al. Characterization, drug release profile and cytotoxicity of Dentatin-Hydroxypropyl-β-Cyclodextrin complex. J Incl Phenom Macrocycl Chem 87, 167–178 (2017). https://doi.org/10.1007/s10847-016-0688-y
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10847-016-0688-y